Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus

Clinical Biochemistry

Volumn 29, Issue 3, 1996, Pages 255-259

  Westerhuis, Lambertus W J J M ^a   Venekamp, Wim J R R ^a  

^a Sittard Geleen Heerlen   (Netherlands)

Author keywords

Fructosamine; HbA1; Microalbuminuria; Retino and or neuropathy

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; FRUCTOSAMINE; HEMOGLOBINS; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 0029968690     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-9120(96)00002-5     Document Type: Article

References (31)

1. Berg K. A new serum type system in man. The Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-382.
2. Sandkamp M, Funke H, Schulte M, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 6: 20-23.
3. Berg K. Lp(a) lipoprotein: An overview. In: Scanu A, editor. Lipoprotein (a). New York: Academic Press, 1990: 1-23.
4. Berg K. Genetics of atherogenic Lp(a) lipoprotein. In: Berg K, Retterstol N, Refsum S, editors. From phenotype to gene in common disorders. Copenhagen: Munksgaard, 1990:138-162.
5. Morton NE, Berg K, Dahlen G, Ferrell RE, Rhoad GG. Genetics of the Lp(a) lipoprotein in Japanese-Americans. Genet Epidemiol 1985; 2: 113-21.
6. Houlston R, Friedl W. Biochemistry and clinical significance of lipoprotein (a) (Review). Ann Clin Biochem 1988; 25: 499-503.
7. Császár A et al. Plasma lipoprotein (a) concentrations and phenotypes in diabetes mellitus. Diabetologia 1993; 36: 47-51.
8. Kapelrud H, Bangstad HJ, Dahl-Jorgensen K, Berg K, Hanssen KF. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 675-678.
9. Jenkins AJ, Steele JS, Janus ED, Best JD. Increased plasma apolipoprotein (a) levels in IDDM patients with microalbuminuria. Diabetes 1991; 40: 787-790.
10. Maioli M et al. Raised serum apolipoprotein(a) in active diabetic retinopathy. Diabetologica 1993; 36: 88-90.
11. Donders SHJ, Lustermans FAT, van Wersch JWJ. The effect of microalbuminuria on glycemic control, serum lipids and haemostasis parameters in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1993; 30: 439-444.
12. Ioven I, Villela E. Serum levels of lipoprotein (a) in patients with well-controlled non-insulin dependent diabetes mellitus. JAMA 1991; 265(9): 1113-1114.
13. Haffner SM, Moss SE, Klein BE, Klein R. Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes. Metabolism 1992; 41(2): 194-197.
14. Ruiz J et al. Association of elevated lipoprotein-a levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein-a phenotypes. Diabetologia 1994; 37: 585-591.
15. Ramirez LC, Araus PC, Lackner C, Albright G, Adams BV, Raskin P. Lipoprotein (a) levels in diabetes mellitus: Relationship to metabolic control. Ann Intern Med 1992; 117: 42-47.
16. Haffner SM, Tuttle KR, Rainwater DL. Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects. Diabetes Care 1991; 14: 302-307.
17. Johnson RN, Metcalf PA, Baker JR. Fructosamine: A new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chim Acta 1982; 127: 87-95.
18. Johnson RN, Baker JR. More on fructosamine assay as index to glycate protein. Clin Chem 1986; 32: 1995-1996.
19. Van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR. HbA1c and serum fructosamine in diabetic patients: Relationship to age, clothing and fibrinolysis parameters and urinary microalbumin excretion. Clin Chim Acta 1991; 201: 99-104.
20. Borch-Johnsen K, Kreiner S. Proteinuria, value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987; 294: 1651-1654.
21. Garcia MJ, McNamara PH, Gordon T, Kannal WB. Morbidity and mortality in diabetes in the Framing-ham population. Diabetes 1974; 23: 105-111.
22. Steiner G. Diabetes and atherosclerosis. Diabetes 1981; 30(2), 1-13.
23. Rowe DJF, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus. Ann Clin Biochem 1990; 27: 297-312.
24. Howard BV. Lipoprotein metabolism in diabetes. J Lipid Res 1987; 28: 613-628.
25. Malec H, Johnson SA, Bjorck S. Relation between serum cholesterol and diabetic nephropathy. Lancet 1990; 335: 1537-1538.
26. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
27. Lyons TJ. Oxidized low density lipoprotein. Diabetic Med 1991; 8: 411-419.
28. Haffner SM, Tuttle KR, Rainwater DL. Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 1992; 41: 116-120.
29. O'Donnel MJ, Bain SC, Barnett AH, Jones A. Lp(a) concentrations. BMJ 1991; 303: 1134.
30. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. J Clin Invest 1987; 80: 458-465.
31. Farrer M, Game FL, Albers CJ, Neil HAW, Winocour PH, Laker MF, Adams PC, Alberti KGMM. Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ 1993; 307: 832-836.